Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of raltegravir in the treatment of HIV-2 infections: evidence from a case series.

Antiviral therapy - 1 Jan 2012

Peterson Kevin, Ruelle Jean, Vekemans Marc, Siegal Frederick P, Deayton Jane R, Colebunders Robert

Abstract excerpt

We describe five patients with HIV-2 infection (four antiretroviral-experienced and one antiretroviral-naive) treated with a regimen containing raltegravir. All responded to treatment as demonstrated by viral load and CD4(+) T-cell count monitoring. Our series confirms the clinical effectiveness of raltegravir in HIV-2-infected patients when given with other antiretrovirals to which the virus is susceptible.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to CD4 Lymphocyte Count

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dideoxynucleosides

Share to Evidence-Based Medicine

Share to Pyrrolidinones

Share to Raltegravir Potassium

Share to Viral Load

Source

Identifiers

PMID: 22892365
DOI: 10.3851/IMP2303

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

The role of raltegravir in the treatment of HIV-2 infections: evidence from a case series.PMID 22892365Read ↗

Raltegravir treatment response in an HIV-2 infected patient: a case reportSemantic proximity Read ↗

Clinical outcome in resistant HIV-2 infection treated with raltegravir and maraviroc.Semantic proximity Read ↗

Dolutegravir for the treatment of HIV-2 infection.Semantic proximity Read ↗

Efficacy and safety of antiretroviral regimens including raltegravir to treat HIV-infected patients with hemophilia.Semantic proximity Read ↗

Antiretroviral drug-resistant HIV-2 infection--a new therapeutic dilemma.Semantic proximity Read ↗

Switch to Ritonavir-Boosted versus Unboosted Atazanavir plus Raltegravir Dual-Drug Therapy Leads to Similar Efficacy and Safety Outcomes in Clinical Practice.Semantic proximity Read ↗

Special Aspects of the Treatment of HIV-2-Infected PatientsSemantic proximity Read ↗

Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND-LINE): a randomised, open-label, non-inferiority studySemantic proximity Read ↗

Novel inhibitors of human immunodeficiency virus type 2 infectivitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.